Table V. Comparison of baseline characteristics for patients with complete data vs patients with incomplete data for the multivariate analysis on linear growth impairment.

			Patients included in multivariate mode
	Total		No		Yes
	n	%	n	%	n	%	χ2 P value
Total	892	100.0	380	100.0	512	100.0
Sex
Male	410	46.0	165	43.4	245	47.9	.1972
Female	482	54.0	215	56.6	267	52.1
Race
Missing	5	0.6	5	1.3	0	0.0	.1231
White	539	60.4	222	58.4	317	61.9
Black	148	16.6	55	14.5	93	18.2
Hispanic	113	12.7	57	15.0	56	10.9
Other	87	9.8	41	10.8	46	9.0
Primary diagnosis
Biliary atresia	289	32.4	133	35.0	156	30.5	.4937
Other cholestatic	142	15.9	52	13.7	90	17.6
Fulminant liver failure	142	15.9	59	15.5	83	16.2
Metabolic disease	164	18.4	70	18.4	94	18.4
Cirrhosis	63	7.1	24	6.3	39	7.6
Other	92	10.3	42	11.1	50	9.8
Age at transplant
<6 mo	39	4.4	19	5.0	20	3.9	<.0001
6-11 mo	103	11.5	46	12.1	57	11.1
1-4 y	228	25.6	123	32.4	105	20.5
5-12 y	381	42.7	148	38.9	233	45.5
13+ y	141	15.8	44	11.6	97	18.9
Donor type
Missing	14	1.6	10	2.6	4	0.8	.0645
Live	120	13.5	50	13.2	70	13.7
Cadaveric whole	541	60.7	212	55.8	329	64.3
Cadaveric reduced	147	16.5	72	18.9	75	14.6
Cadaveric split	70	7.8	36	9.5	34	6.6
Patient status at transplant
Missing	5	0.6	5	1.3	0	0.0	.7720
ICU	197	22.1	79	20.8	118	23.0
Hospitalized, not in ICU	124	13.9	54	14.2	70	13.7
Not hospitalized	566	63.5	242	63.7	324	63.3
Height failure at transplant
Missing	111	12.4	111	29.2	0	0.0	.2024
No	519	58.2	187	49.2	332	64.8
Yes	262	29.4	82	21.6	180	35.2
Re-transplanted
No	813	91.1	341	89.7	472	92.2	.2334
Yes	79	8.9	39	10.3	40	7.8